Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 17451464)

1.

Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Vasilevsky S, Greub G, Nardelli-Haefliger D, Baud D.

Clin Microbiol Rev. 2014 Apr;27(2):346-70. doi: 10.1128/CMR.00105-13. Review.

2.

Kinetics of pulmonary immune cells, antibody responses and their correlations with the viral clearance of influenza A fatal infection in mice.

Lv J, Hua Y, Wang D, Liu A, An J, Li A, Wang Y, Wang X, Jia N, Jiang Q.

Virol J. 2014 Mar 26;11:57. doi: 10.1186/1743-422X-11-57.

3.

Evasion of influenza A viruses from innate and adaptive immune responses.

van de Sandt CE, Kreijtz JH, Rimmelzwaan GF.

Viruses. 2012 Sep;4(9):1438-76. doi: 10.3390/v4091438. Epub 2012 Sep 3. Review.

4.

Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.

Chen A, Poh SL, Dietzsch C, Roethl E, Yan ML, Ng SK.

BMC Biotechnol. 2011 Aug 11;11:81. doi: 10.1186/1472-6750-11-81.

5.

Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.

Eko FO, Okenu DN, Singh UP, He Q, Black C, Igietseme JU.

Vaccine. 2011 May 12;29(21):3802-10. doi: 10.1016/j.vaccine.2011.03.027. Epub 2011 Mar 21.

6.

Induction of immune memory by a multisubunit chlamydial vaccine.

Eko FO, Ekong E, He Q, Black CM, Igietseme JU.

Vaccine. 2011 Feb 4;29(7):1472-80. doi: 10.1016/j.vaccine.2010.12.024. Epub 2010 Dec 22. Erratum in: Vaccine. 2011 Apr 27;29(19):3623-4.

7.

Novel Chlamydia pneumoniae vaccine candidates confirmed by Th1-enhanced genetic immunization.

Li Y, Ahluwalia SK, Borovkov A, Loskutov A, Wang C, Gao D, Poudel A, Sykes KF, Kaltenboeck B.

Vaccine. 2010 Feb 10;28(6):1598-605. doi: 10.1016/j.vaccine.2009.11.046. Epub 2009 Dec 2.

8.

Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Igietseme JU, He Q, Joseph K, Eko FO, Lyn D, Ananaba G, Campbell A, Bandea C, Black CM.

J Infect Dis. 2009 Sep 15;200(6):926-34. doi: 10.1086/605411.

9.

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P.

Vaccine. 2009 Jun 8;27(28):3766-74. doi: 10.1016/j.vaccine.2009.03.090. Epub 2009 Apr 23.

10.

A vault nanoparticle vaccine induces protective mucosal immunity.

Champion CI, Kickhoefer VA, Liu G, Moniz RJ, Freed AS, Bergmann LL, Vaccari D, Raval-Fernandes S, Chan AM, Rome LH, Kelly KA.

PLoS One. 2009;4(4):e5409. doi: 10.1371/journal.pone.0005409. Epub 2009 Apr 30.

11.

A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Ekong EE, Okenu DN, Mania-Pramanik J, He Q, Igietseme JU, Ananaba GA, Lyn D, Black C, Eko FO.

FEMS Immunol Med Microbiol. 2009 Mar;55(2):280-91. doi: 10.1111/j.1574-695X.2008.00493.x. Epub 2008 Nov 18.

12.

Involvement of LEK1 in dendritic cell regulation of T cell immunity against Chlamydia.

He Q, Eko FO, Lyn D, Ananaba GA, Bandea C, Martinez J, Joseph K, Kellar K, Black CM, Igietseme JU.

J Immunol. 2008 Sep 15;181(6):4037-42.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk